Latest net income for IMMP: $-140M, below the Healthcare sector average of $16B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
Immutep Limited (IMMP) currently reports a net income of $-140M as of June 2026. That compares with $-83M in the prior-year period — down 70.9% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Immutep Limited's net income history and peer comparisons.
Immutep Limited's net income decreased from $-83M to $-140M — a 70.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Immutep Limited's net income of $-140M is lower than the Healthcare sector average of $16B. That is roughly 100.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Immutep Limited reported $-140M in net income as of June 2026. That compares with $-83M in the prior-year period — down 70.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net income of $-140M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Immutep Limited, and consider following IMMP for alerts when major investors trade the stock.